Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houda Bahig

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Current Oncology (Toronto, Ont.)|December 22, 2023
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi ProcessJames Tankel, Jonathan Spicer, Quincy Chu, et al.
Trials|April 24, 2026
Platform for the Evaluation of innovations in Radiation oncology through registry-based conduct of multi-centric pragmatic randomized trials: PERa implementationPhilippe Giguère, Houda Bahig, Sydney Westra, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
<b>S</b>tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)Houda Bahig, Marion Tonneau, Normand Blais, et al.
Head & Neck|May 11, 2023
Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experienceHouda Bahig, Hanna Y Ehab, Adam S Garden, et al.
BMC Cancer|December 13, 2019
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trialDavid A Palma, Hanbo Chen, Houda Bahig, et al.
British Journal of Cancer|October 14, 2020
Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapySweet Ping Ng, Houda Bahig, Amit Jethanandani, et al.
Physics in Medicine and Biology|July 4, 2019
Biomechanical modeling of neck flexion for deformable alignment of the salivary glands in head and neck cancer imagesMolly M McCulloch, Brian M Anderson, Guillaume Cazoulat, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 30, 2025
Artificial Intelligence Model for Imaging-Based Extranodal Extension Detection and Outcome Prediction in Human Papillomavirus-Positive Oropharyngeal CancerGabriel S Dayan, Gautier Hénique, Houda Bahig, et al.
Oral Oncology|November 10, 2023
Predictors of prolonged treatment time intervals in oral cavity cancerGabriel Dayan, Houda Bahig, Bernard Fortin, et al.
BMC Cancer|January 16, 2019
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinomaHouda Bahig, Francine Aubin, John Stagg, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Current Oncology (Toronto, Ont.)|December 22, 2023
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi ProcessJames Tankel, Jonathan Spicer, Quincy Chu, et al.
Trials|April 24, 2026
Platform for the Evaluation of innovations in Radiation oncology through registry-based conduct of multi-centric pragmatic randomized trials: PERa implementationPhilippe Giguère, Houda Bahig, Sydney Westra, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
<b>S</b>tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)Houda Bahig, Marion Tonneau, Normand Blais, et al.
Head & Neck|May 11, 2023
Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experienceHouda Bahig, Hanna Y Ehab, Adam S Garden, et al.
BMC Cancer|December 13, 2019
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trialDavid A Palma, Hanbo Chen, Houda Bahig, et al.
British Journal of Cancer|October 14, 2020
Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapySweet Ping Ng, Houda Bahig, Amit Jethanandani, et al.
Physics in Medicine and Biology|July 4, 2019
Biomechanical modeling of neck flexion for deformable alignment of the salivary glands in head and neck cancer imagesMolly M McCulloch, Brian M Anderson, Guillaume Cazoulat, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 30, 2025
Artificial Intelligence Model for Imaging-Based Extranodal Extension Detection and Outcome Prediction in Human Papillomavirus-Positive Oropharyngeal CancerGabriel S Dayan, Gautier Hénique, Houda Bahig, et al.
Oral Oncology|November 10, 2023
Predictors of prolonged treatment time intervals in oral cavity cancerGabriel Dayan, Houda Bahig, Bernard Fortin, et al.
BMC Cancer|January 16, 2019
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinomaHouda Bahig, Francine Aubin, John Stagg, et al.
Pageof 14